These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24028192)

  • 1. Impairment and disability in 20 CIDP patients according to disease activity status.
    Panaite PA; Renaud S; Kraftsik R; Steck AJ; Kuntzer T
    J Peripher Nerv Syst; 2013 Sep; 18(3):241-6. PubMed ID: 24028192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes.
    Alabdali M; Abraham A; Alsulaiman A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    J Neurol Sci; 2017 Jan; 372():223-227. PubMed ID: 28017218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Peric S; Bozovic I; Pruppers MHJ; Bjelica B; Stevic Z; Faber CG; Merkies ISJ; Basta I
    J Peripher Nerv Syst; 2019 Sep; 24(3):260-267. PubMed ID: 31397933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease activity in chronic inflammatory demyelinating polyneuropathy.
    Albulaihe H; Alabdali M; Alsulaiman A; Abraham A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    J Neurol Sci; 2016 Oct; 369():204-209. PubMed ID: 27653889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Peric S; Gwathmey K; Sadjadi R; Bozovic I; Burns TM; Basta I
    J Peripher Nerv Syst; 2019 Sep; 24(3):247-252. PubMed ID: 31209940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study.
    Merkies IS; Hughes RA; Donofrio P; Bril V; Dalakas MC; Hanna K; Hartung HP; Latov N; van Doorn PA; Deng C;
    J Peripher Nerv Syst; 2010 Sep; 15(3):208-15. PubMed ID: 21040143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy.
    van Veen R; Pallada G; Wieske L; Ten Holter SEM; van Rootselaar AF; Verhamme C; de Bie RMA; van Schaik IN; Merkies ISJ; Dijk JM; Eftimov F
    J Peripher Nerv Syst; 2023 Mar; 28(1):58-68. PubMed ID: 36571466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor unit number index (MUNIX) in chronic inflammatory demyelinating polyneuropathy: A potential role in monitoring response to intravenous immunoglobulins.
    Lawley A; Seri S; Rajabally YA
    Clin Neurophysiol; 2019 Oct; 130(10):1743-1749. PubMed ID: 31400577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?
    Delmont E; Benvenutto A; Grimaldi S; Duprat L; Philibert M; Pouget J; Grapperon AM; Salort-Campana E; Sévy A; Verschueren A; Attarian S
    Clin Neurophysiol; 2016 Mar; 127(3):1891-4. PubMed ID: 26750580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison.
    Vanhoutte EK; Draak TH; Gorson KC; van Nes SI; Hoeijmakers JG; Van der Pol WL; Notermans NC; Lewis RA; Nobile-Orazio E; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
    J Peripher Nerv Syst; 2015 Sep; 20(3):289-95. PubMed ID: 26114893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
    Klehmet J; Beutner S; Hoffmann S; Dornauer M; Paul F; Reilmann R; Brandt AU; Meisel A
    BMC Neurol; 2019 Jun; 19(1):118. PubMed ID: 31176377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome in chronic inflammatory demyelinating polyneuropathy from a Malaysian centre over sixteen years.
    Hiew FL; Ong JJ; Viswanathan S; Puvanarajah S
    J Clin Neurosci; 2018 Apr; 50():203-207. PubMed ID: 29398193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
    Boukhris S; Magy L; Khalil M; Sindou P; Vallat JM
    J Neurol Sci; 2007 Mar; 254(1-2):33-8. PubMed ID: 17286985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Bozovic I; Kacar A; Peric S; Nikolic A; Bjelica B; Cobeljic M; Petrovic M; Stojanov A; Djuric V; Stojanovic M; Djordjevic G; Martic V; Dominovic A; Vukojevic Z; Basta I
    J Neurol; 2017 Dec; 264(12):2481-2486. PubMed ID: 29086018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
    Wadwekar V; Kalita J; Misra UK
    Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
    Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance of the nerve biopsy for the diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuritis: 8 cases].
    Vallat JM; Tabaraud F; Magy L; Couratier P
    Bull Acad Natl Med; 2003; 187(2):387-99; discussion 399-403. PubMed ID: 14556448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year follow-up study of neuropathic pain in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Peric S; Bozovic I; Kacar A; Cobeljic M; Dejanovic I; Stevic Z; Basta I
    J Peripher Nerv Syst; 2019 Jun; 24(2):180-186. PubMed ID: 30973184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice.
    Gorson KC; van Schaik IN; Merkies IS; Lewis RA; Barohn RJ; Koski CL; Cornblath DR; Hughes RA; Hahn AF; Baumgarten M; Goldstein J; Katz J; Graves M; Parry G; van Doorn PA
    J Peripher Nerv Syst; 2010 Dec; 15(4):326-33. PubMed ID: 21199104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance.
    Merkies IS; van Nes SI; Hanna K; Hughes RA; Deng C
    J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1194-9. PubMed ID: 20647554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.